OBJECTIVES This study sought to describe the frequency and clinical impact of acute scaffold disruption and late strut discontinuity of the second-generation Absorb bioresorbable polymeric vascular scaffolds (Absorb BVS, Abbott Vascular, Santa Clara, California) in the ABSORB (A Clinical Evaluation of the Bioabsorbable Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions) cohort B study by optical coherence tomography (OCT) post-procedure and at 6, 12, 24, and 36 months. BACKGROUND Fully bioresorbable scaffolds are a novel approach to treatment for coronary narrowing that provides transient vessel support with drug delivery capability without the long-term limitations of ...
textabstractIntroduction: Although bioresorbable vascular scaffolds (BVS) have been used with promis...
Background: We investigated whether optical coherence tomography (OCT) guidance would reduce nonopt...
Background—Everolimus-eluting bioresorbable vascular scaffolds have been developed to improve late o...
AbstractObjectivesThis study sought to describe the frequency and clinical impact of acute scaffold ...
OBJECTIVES: The introduction of the bioresorbable vascular scaffold (BVS) has led to new avenues of ...
BACKGROUND: The long-term fate of Absorb bioresorbable vascular scaffold (Abbott Vascular, Santa Cla...
ObjectivesThe aim of this study was to demonstrate that the prevention of early scaffold area shrink...
BACKGROUND The long-term fate of Absorb bioresorbable vascular scaffold (Abbott Vascular, Santa C...
ObjectivesThis study sought to demonstrate the 5-year clinical and functional multislice computed to...
OBJECTIVES: This study sought to assess the vascular response of overlapping Absorb stents compared...
Aims: To assess observations with multimodality imaging of the Absorb bioresorbable everolimus-eluti...
Purpose: Data regarding vessel healing by optical coherence tomography (OCT) after everolimus-elutin...
ObjectivesThis study sought to assess the vascular response of overlapping Absorb stents compared wi...
Background: Bioresorbable vascular scaffold (BVS) implantation is a new, promising treatment method...
Objectives: The aim of this study was to investigate the vascular responses and fates of the scaffol...
textabstractIntroduction: Although bioresorbable vascular scaffolds (BVS) have been used with promis...
Background: We investigated whether optical coherence tomography (OCT) guidance would reduce nonopt...
Background—Everolimus-eluting bioresorbable vascular scaffolds have been developed to improve late o...
AbstractObjectivesThis study sought to describe the frequency and clinical impact of acute scaffold ...
OBJECTIVES: The introduction of the bioresorbable vascular scaffold (BVS) has led to new avenues of ...
BACKGROUND: The long-term fate of Absorb bioresorbable vascular scaffold (Abbott Vascular, Santa Cla...
ObjectivesThe aim of this study was to demonstrate that the prevention of early scaffold area shrink...
BACKGROUND The long-term fate of Absorb bioresorbable vascular scaffold (Abbott Vascular, Santa C...
ObjectivesThis study sought to demonstrate the 5-year clinical and functional multislice computed to...
OBJECTIVES: This study sought to assess the vascular response of overlapping Absorb stents compared...
Aims: To assess observations with multimodality imaging of the Absorb bioresorbable everolimus-eluti...
Purpose: Data regarding vessel healing by optical coherence tomography (OCT) after everolimus-elutin...
ObjectivesThis study sought to assess the vascular response of overlapping Absorb stents compared wi...
Background: Bioresorbable vascular scaffold (BVS) implantation is a new, promising treatment method...
Objectives: The aim of this study was to investigate the vascular responses and fates of the scaffol...
textabstractIntroduction: Although bioresorbable vascular scaffolds (BVS) have been used with promis...
Background: We investigated whether optical coherence tomography (OCT) guidance would reduce nonopt...
Background—Everolimus-eluting bioresorbable vascular scaffolds have been developed to improve late o...